Diagnosis and Management of Endomyocardial Fibrosis

Endomyocardial fibrosis (EMF) remains an important cause of restrictive cardiomyopathy worldwide. Patients cluster in specific geographic locations and are almost universally living in extreme poverty. Specific etiology remains elusive and is likely multifactorial. Untreated EMF has a very poor prog...

Full description

Saved in:
Bibliographic Details
Published inCardiology clinics Vol. 35; no. 1; p. 87
Main Authors Beaton, Andrea, Mocumbi, Ana Olga
Format Journal Article
LanguageEnglish
Published Netherlands 01.02.2017
Subjects
Disease Management
Endomyocardial Fibrosis - diagnosis
Endomyocardial Fibrosis - epidemiology
Endomyocardial Fibrosis - therapy
Global Health
Humans
Incidence
Prognosis
Heart failure
Restrictive cardiomyopathy
Endomyocarial fibrosis
Neglected diseases
Online AccessGet more information

Cover

More Information
Summary:Endomyocardial fibrosis (EMF) remains an important cause of restrictive cardiomyopathy worldwide. Patients cluster in specific geographic locations and are almost universally living in extreme poverty. Specific etiology remains elusive and is likely multifactorial. Untreated EMF has a very poor prognosis. Medical management can mitigate symptoms for a time but has no curative benefit. Early surgical interventions may improve survival but are not readily available in most EMF-endemic regions. Increased awareness, advocacy, and research are needed to further understand this neglected tropical cardiomyopathy and to improve survival of those affected.
ISSN:1558-2264
DOI:10.1016/j.ccl.2016.08.005